Follow Us On Social Media


NeuroTopic: Neuromuscular & Immune Disorders

Filter Your Results




Amyotrophic Lateral Sclerosis with Atrophy of the Amygdala

Felix Geser, MD, PhD, Leo Hermle, MD, Patrick J. Egan, MD, Johannes Brettschneider, MD, and Tibor C. G. Mitrovics, MD

July/August 2016—Early and pronounced involvement of the amygdala is known to be characteristic for the behavioral variant of frontotemporal dementia, but it may also occur in ALS.

Special Report: AAN Annual Meeting: Video Coverage, Study Highlights, and More

May 2016— Last month, thousands of members of the international neurology community convened in Vancouver for the Annual Meeting of the American Academy of Neurology (AAN). Practical …

In-Focus: Communication

May 2016—Review Finds Poor Public Understanding of Dementia Findings from a new review indicate that the general public possesses only a fair to moderate knowledge and understanding…

ACTRIMS 2016 Forum Coverage: Updates in MS Therapeutics and Research

Ted Pigeon, Editor-in-Chief

March 2016—Last month, experts in multiple sclerosis (MS) research and treatment convened in New Orleans, LA for The Americas Committee for Treatment and Research in Multiple Sclerosis (…

Early Diagnosis, Effective Patient Partnerships, and Other Keys to Optimizing Multiple Sclerosis Therapy

Patricia K. Coyle, MD

March 2016—Standardizing imaging protocols and employing strategies to boost adherence can lead to better treatment outcomes.

Preferred Treatment: The Changing Economics of Multiple Sclerosis Care

Thomas P. Leist, MD, PhD

March 2016—By deciding which drugs are “preferred,” insurance companies are reducing the practice of evidence-based medicine to a series of economic choices.

Study Spotlight: Patient Activation and the Psychosocial Impact of Multiple Sclerosis

March 2016—Routine assessment for psychological comorbidities is essential in the overall care of patients with multiple sclerosis.

Ocrelizumab and the Next Phase in Multiple Sclerosis Therapy

Thomas Leist, MD, PhD

November/December 2015—Advances in immune therapy may change how scientists and clinicians understand neurodegenerative components of MS.


Contact Info

For advertising rates and opportunities:
Steve Farrell

About Practical Neurology

Launched in January 2002, Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.